What evidence is there to support the prescribing of exenatide for adults patients who are already prescribed insulin with type? - Literature review Example

Extract of sample
What evidence is there to support the prescribing of exenatide for adults patients who are already prescribed insulin with type?

In insulin dependent patients with type 2 diabetes, especially with obesity, control of glycemia is a challenging issue (Hood et al, 2006). Intensification of insulin therapy to achieve target levels of glycosylated hemoglobin leads to further weight gain. Infact, one of main anxieties with insulin therapy in this population is poor weight gain (Nayak et al, 2010). In several developed countries like UK, there are recommendations for obesity surgery, along with exercise, diet and drug control of diabetes. However, obesity surgery is associated with significant risk. Exenatide, when given as an adjunct to insulin therapy, has been proven to not only achieve better control of blood glucose levels, but also decrease the chances of gaining weight. Infact, some studies have demonstrated weight loss with exenatide therapy. In this article, evidence to support the prescription of exenatide, as an adjunct to insulin therapy will be discussed through review of suitable literature.
Understanding the pathophysiology and treatment basis of diabetes type-2
Diabetes mellitus can be defined as a group of clinical syndromes characterized by hyperglycemia arising as a result of absolute or relative insulin deficiency (Edwards et al, 2002). There are basically 2 types of diabetes mellitus. ...
Download paper

Summary

The homeostasis of glucose in human body is mainly regulated by an interplay of several hormones. The interplay is complex and involves hormones like insulin, amylin and glucagon from pancreas and glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 or GLP-1 from gut…
Author : brucepurdy
Download 1
Got a tricky question? Receive an answer from students like you! Try us!